Assessing the measure of a new drug: is survival the only thing that matters?
- PMID: 18421044
- DOI: 10.1200/JCO.2007.14.8064
Assessing the measure of a new drug: is survival the only thing that matters?
Comment on
-
Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.J Clin Oncol. 2008 Apr 20;26(12):1987-92. doi: 10.1200/JCO.2007.10.8407. J Clin Oncol. 2008. PMID: 18421050
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
